GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TWi Biotechnology Inc (ROCO:6610) » Definitions » Sale Of Investment

TWi Biotechnology (ROCO:6610) Sale Of Investment : NT$139.73 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is TWi Biotechnology Sale Of Investment?

TWi Biotechnology's sale of investment for the six months ended in Jun. 2024 was NT$139.73 Mil. It means TWi Biotechnology gained NT$139.73 Mil from selling investments. TWi Biotechnology's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was NT$139.73 Mil.

Compared with last quarter (NT$0.00 Mil in Dec. 2023 ), TWi Biotechnology gained more money from selling investments in Jun. 2024 (NT$139.73 Mil).


TWi Biotechnology Sale Of Investment Historical Data

The historical data trend for TWi Biotechnology's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TWi Biotechnology Sale Of Investment Chart

TWi Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 302.66 329.02 227.20 35.30 -

TWi Biotechnology Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.30 - - - 139.73

TWi Biotechnology Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$139.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TWi Biotechnology Sale Of Investment Related Terms

Thank you for viewing the detailed overview of TWi Biotechnology's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


TWi Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494
TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

TWi Biotechnology Headlines

No Headlines